Is ABBV or ELV cheaper?

On trailing earnings, ELV is cheaper: ABBV trades at a 111.67 P/E and ELV at 17.19.

Which has grown faster, ABBV or ELV?

Over the past five years, ELV grew revenue faster — ABBV at a 4.59% CAGR versus ELV at 9.97%.

Does ABBV or ELV pay a bigger dividend?

ABBV yields 2.96% and ELV yields 1.70% based on trailing dividends and the latest price.

Is ABBV or ELV more profitable?

ABBV runs the higher net margin — ABBV at 5.79% versus ELV at 2.62%.

Which has been the better investment, ABBV or ELV?

Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus ELV at 13.43%. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Elevance Health Inc. (ELV)

ABBV leads on 8 of 15 compared metrics, though ELV is the cheaper stock.

A side-by-side comparison of AbbVie Inc. and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ABBV vs ELV

growth of $100 · last 14y

ABBV +544.8%ELV +586.1%ELV compounded faster

ABBV ELV

ABBV vs ELV: by the numbers

•ABBV is the larger company ($402.35B vs $87.75B market cap).
•ELV trades at the lower earnings multiple (17.19 vs 111.67 P/E).
•ABBV converts more revenue to profit (5.79% vs 2.62% net margin).
•ELV grew revenue faster over the past five years (9.97% vs 4.59% CAGR).
•ABBV pays the higher dividend yield (2.96% vs 1.70%).

Which is better, ABBV or ELV?

Metric tally: ABBV 8 · ELV 7

It depends on what you're optimizing for:

ValueELV(lower P/E)

GrowthELV(faster 5Y revenue CAGR)

IncomeABBV(higher dividend yield)

QualityABBV(higher ROIC)

Valuation

Metric	ABBV	ELV
P/E ratio	111.67	17.19●
Forward P/E	—	13.82
P/S ratio	6.43	0.44●
P/B ratio	14.69	2.03●
PEG ratio	—	2.58
EV / EBITDA	27.63	12.48●
FCF yield	5.17%	7.24%●

Profitability

Metric	ABBV	ELV
Gross margin	70.68%●	23.16%
Operating margin	27.60%●	3.81%
Net margin	5.79%●	2.62%
ROE	13.23%●	11.94%
ROIC	12.97%●	6.65%

Dividends

Metric	ABBV	ELV
Dividend yield	2.96%●	1.70%
Payout ratio	284.39%	27.24%

Growth (annualized)

Metric	ABBV	ELV
Revenue CAGR (5Y)	4.59%	9.97%●
EPS CAGR (5Y)	-2.79%	6.67%●
FCF CAGR (5Y)	3.24%●	-7.76%
Total return CAGR (5Y)	18.95%●	2.50%

Frequently asked

Which is better, ABBV or ELV?: It depends on your goal. value: ELV (lower P/E); growth: ELV (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, ABBV leads 8 to 7.
Is ABBV or ELV cheaper?: On trailing earnings, ELV is cheaper: ABBV trades at a 111.67 P/E and ELV at 17.19.
Which has grown faster, ABBV or ELV?: Over the past five years, ELV grew revenue faster — ABBV at a 4.59% CAGR versus ELV at 9.97%.
Does ABBV or ELV pay a bigger dividend?: ABBV yields 2.96% and ELV yields 1.70% based on trailing dividends and the latest price.
Is ABBV or ELV more profitable?: ABBV runs the higher net margin — ABBV at 5.79% versus ELV at 2.62%.
Which has been the better investment, ABBV or ELV?: Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus ELV at 13.43%. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full ELV analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Elevance Health P/E ratio AbbVie dividend yield Elevance Health dividend yield AbbVie ROE Elevance Health ROE AbbVie operating margin Elevance Health operating margin AbbVie revenue growth Elevance Health revenue growth AbbVie free cash flow Elevance Health free cash flow

AbbVie & Elevance Health appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.